Conor MedSystems
Conor MedSystems was a Menlo Park-based developer of controlled vascular drug delivery technology, founded in 1999 and once listed on NASDAQ as CONR; the company is now delisted and its corporate domain is parked, with no active independent operations evidenced in the input data.
- Company typePrivate
- Founded1999
- HeadquartersMenlo Park, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Conor MedSystems does
Conor MedSystems was founded in 1999 and headquartered in Menlo Park, California, with a stated mission to develop innovative controlled vascular drug delivery technology — most plausibly a regulated medical device platform in the drug-delivery or drug-eluting interventional cardiology category based on the firm's description and regulatory exposure. The company was led by Frank Litvack as Chairman and CEO and at one point scaled its workforce into the 501–1,000 employee range, suggesting a meaningful clinical, regulatory, and commercial build-out during its operating period.
Financially, Conor MedSystems raised approximately $38 million across two disclosed venture rounds in 2002 and 2003, with Highland Capital Partners leading the $10 million round in 2002 and Easton Capital leading the $28 million round in 2003. The company subsequently listed on NASDAQ under the ticker CONR but is now delisted, and its primary corporate domain (conormed.com) currently resolves to a parked GoDaddy landing page hosting unrelated third-party men's health content, indicating the entity is no longer operating as an independent, revenue-generating business based on the available evidence. The input data does not disclose pricing models, product SKUs, named customers, geographic footprint, ownership, or acquisition history.
Conor MedSystems firmographics
Firmographics- Name
- Conor MedSystems
- Website
- https://conormed.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Conor MedSystems was a Menlo Park-based developer of controlled vascular drug delivery technology, founded in 1999 and once listed on NASDAQ as CONR; the company is now delisted and its corporate domain is parked, with no active independent operations evidenced in the input data.
- Ownership category
- akta.pro rank
Where Conor MedSystems is headquartered
LocationHeadquarters
- HQ city
- Menlo Park
- HQ country
- United States
- HQ region
- North America
Markets served
Conor MedSystems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Others
Conor MedSystems product offering
Product offeringCore offering
Conor MedSystems developed controlled vascular drug delivery technology centered on drug-eluting coronary stents for interventional cardiology. Its proprietary platform was designed to deliver therapeutic agents directly to vessel walls via stent-based scaffolds, targeting the treatment of coronary artery disease. The company was a Menlo Park, California-based medical device developer founded in 1999.
Product overview
Conor MedSystems operates a telemedicine platform for men's health, specifically focused on erectile dysfunction (ED) treatments. The platform offers online consultations with healthcare providers and dispenses ED medications including sildenafil and tadalafil. The source material does not provide details on the company's specific product portfolio or service architecture.
Differentiator
Problem solved
Functional benefit
Products and services
- Controlled Vascular Drug Delivery Stent System A drug-eluting coronary stent platform designed to deliver therapeutic agents directly to the vessel wall via a reservoir-based scaffold, intended for use by interventional cardiologists treating coronary artery disease through percutaneous coronary intervention (PCI).
Companies that use Conor MedSystems
Customer profileIdeal customer profiles1 record
Conor MedSystems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Conor MedSystems partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights1 record
Conor MedSystems competitors and assessment
Company assessmentMarket position
Weaknesses4 records
Competitive moat2 records
Customer concentration
Conor MedSystems social profiles
Digital presenceConor MedSystems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Conor MedSystems leadership team
Management profileNumber of profiles
Profiles1 record
Conor MedSystems funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Conor MedSystems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Conor MedSystems
What does Conor MedSystems do?
Conor MedSystems developed controlled vascular drug delivery technology centered on drug-eluting coronary stents for interventional cardiology. Its proprietary platform was designed to deliver therapeutic agents directly to vessel walls via stent-based scaffolds, targeting the treatment of coronary artery disease. The company was a Menlo Park, California-based medical device developer founded in 1999.
When was Conor MedSystems founded?
Conor MedSystems was founded in 1999. It employs 501 to 1,000 people.
Where is Conor MedSystems based?
Conor MedSystems is headquartered in Menlo Park, United States, in the North America region.
Does Conor MedSystems have an API?
No public API is recorded for Conor MedSystems.